MethylGene Inc. (TSX:MYG) today announced the appointment of Mr. Jay Moorin, Partner at ProQuest Investments III, L.P., to MethylGene's Board of Directors. Mr. Moorin's appointment fills the vacancy created by Mr. Leon Moulder, Jr., President and Chief Executive Officer of MGI Pharma Inc. who resigned to fulfill his other growing professional obligations.
